April 17, 2023 Comments Off on New patent for Janssen Pharms drug INVOKAMET Posted in: Patent Added Annual Drug Patent Expirations for INVOKAMET Invokamet is a drug marketed by Janssen Pharms and is included in two NDAs. It is available from one supplier. There are five patents…
The post New patent for Janssen Pharms drug INVOKAMET appeared first on …
April 17, 2023 Comments Off on New patent for Nevakar Injectables drug NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE Posted in: Patent Added Annual Drug Patent Expirations for NOREPINEPHRINE+BITARTRATE+IN+0.9%25+SODIUM+CHLORIDE Norepinephrine Bitartrate In 0.9% Sodium Chloride is a drug marketed by Inforlife and Nevakar Injectables and is included in two NDAs. It is available…
The post New …